International Society for Extracellular Vesicles 2025

Join us on April 24–27 as we explore the latest breakthroughs in EV research and innovation. Don’t miss our CTO Ola Tuvesson presenting a poster “Progressing bacterial-derived extracellular vesicles to clinical stage”, poster #1308.

This annual meeting is a hub for scientific exchange, collaboration, and connection — and we’re looking forward to meeting peers, partners, and pioneers shaping the future of advanced therapies.

When: April 24-27, 2025
Where: Vienna, Austria

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on LinkedIn